January 20, 2023

Lance Hill in PharmExec: a bright future for medical affairs

Within3’s CEO shares how technology offers a tech-enabled way forward.
tech enabled future of medical affairs

Within3 CEO Lance Hill recently presented a compelling vision of the tech-enabled future of medical affairs: one where processes and people are tech-enabled to achieve better results.

After Hill’s talk, PharmExec grabbed a few minutes to hear more about the changing role of medical affairs, what data insights medical affairs may need and how AI, analytics, and technology, like an insights management platform, can help in the medical affairs role.

There’s a tremendous amount of interest in really understanding artificial intelligence, and how artificial intelligence is directly impacting this idea of bringing in insights from the field – unstructured text and notes, basically – and being able to turn them into action very quickly.

For medical affairs teams, what is the impact of being able to act in response to new information? Organizations may be able to shorten development timelines, avoid delays across all stages of the product life cycle, and ultimately get treatments to patients faster.

Get more insights in this short video.

Related Posts:

pharma and women's health

Within3 in Journal of mHealth: how can pharma address gender inequality in healthcare?

Life science companies can use technology to correct drug development and healthcare inequalities.
med tech improves pharma's public image

Within3 in Journal of mHealth: How Med Tech Improves the Public Image of Pharma

Pharma success is dependent on the trust of the public, patients, and trial participants. Tech can help companies maintain a positive image and constituent trust.
how AI can help pharma teams

Within3 in PharmExec: how artificial intelligence can help pharma teams collect and analyze data

Within3 CTO, AI & Analytics Jason Smith talks to PharmExec about AI, compliance, and the patient experience.